SEC Filing Analysis: SANGAMO THERAPEUTICS, INC (SGMO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer disposed of shares to cover mandatory tax withholding on vesting Restricted Stock Units (RSUs), a common and non-discretionary event.
• Market Impact: Neutral. This transaction is automatic and does not signal a change in insider sentiment. It is too small to impact the stock price.

Company Information

Field	Value
Company	SANGAMO THERAPEUTICS, INC
Ticker Symbol	SGMO
CIK	0001001233
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Dubois-Stringfellow Nathalie
CIK	0001947007
Title/Position	SVP-CHIEF DEVELOPMENT OFFICER
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-22
Transaction Code	F - Payment of tax liability by withholding securities
Security Type	Common Stock
Shares Involved	43,741
Price Per Share	$0.66
Total Value	$28,869.06
Shares Owned After	722,348
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$28,869.06
% of Market Cap	0.015%
Shares Transacted	43,741
% of Shares Outstanding	0.014%
Post-Transaction Ownership	722,348 shares (0.239% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For Sangamo Therapeutics, a company with a market capitalization of approximately $190 million, this $29k transaction is immaterial, representing just 0.015% of its market value.
• Ownership Concentration: The insider's post-transaction ownership of 722,348 shares constitutes a minor 0.24% of total shares outstanding, indicating low ownership concentration from this specific executive.
• Dilution Impact: This transaction is a disposition to cover taxes on previously granted shares, not a new issuance, so it has no dilutive impact.
• Transaction Significance: The transaction's value and share count are far below the thresholds for significance (>1% of market cap or >0.5% of shares outstanding). The nature of the transaction (automatic tax withholding) further reduces its importance as a market signal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is a routine, non-discretionary event required to cover tax liabilities from vesting equity compensation. It does not represent a voluntary decision by the insider to sell shares on the open market and therefore carries no sentiment signal.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction is an internal disposition to the issuer and does not affect public trading volume.
• Sentiment Indicator: Neutral. This type of filing is informational and should not be interpreted as either bullish or bearish.

Investment Insights

Positive Market Indicators

• The insider continues to hold a substantial position of 722,348 shares after the transaction.

Risk Factors

• No new risk factors are indicated by this filing.

Key Takeaways

1. Non-Discretionary Event: The filing reports a mandatory tax withholding, not a discretionary open-market sale.
2. Immaterial Size: The transaction value is less than $30,000, representing a negligible fraction (0.015%) of the company's market cap.
3. No Change in Sentiment: This type of transaction does not reflect the insider's outlook on the company's future performance.

Additional Context

Transaction Notes

• Special Circumstances: As detailed in Footnote 1, the shares were surrendered "solely for mandatory tax withholding purposes" related to the vesting of an RSU grant. This is not an open-market trade.
• Market Environment: The transaction is a routine corporate action related to executive compensation and is independent of the broader market environment.